JACK R WANDS, MD
Osteopathic Medicine at Wampanoag Trl, East Providence, RI
License number
Rhode Island MD09974
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
375 Wampanoag Trl SUITE 202A, East Providence, RI 02915
17 Virginia Ave SUITE 107, Providence, RI 02905
17 Virginia Ave SUITE 107, Providence, RI 02905
Phone
(401) 649-4030
(401) 649-4031 (Fax)
(401) 443-4992
(401) 784-4902 (Fax)
(401) 649-4031 (Fax)
(401) 443-4992
(401) 784-4902 (Fax)
Personal information
See more information about JACK R WANDS at radaris.comName
Address
Phone
1040 High Hawk Rd, East Greenwich, RI 02818
50 Park Row W, Providence, RI 02903
50 Park St, Providence, RI 02903
50 Park Row W, Providence, RI 02903
Professional information
Jack Raymond Wands, Providence RI
Specialties:
Internal Medicine, Gastroenterology, Psychiatry
Work:
Rhode Island Hospital
593 Eddy St, Providence, RI 02903
593 Eddy St, Providence, RI 02903
Education:
University of Washington (1969)
Dr. Jack R Wands, Providence RI - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Providence Office
593 Eddy St, Providence 02903
(401) 444-5120 (Phone), (401) 444-4307 (Fax)
Univ Medicine Gastroenterology
110 Lockwood St SUITE 116, Providence 02903
(401) 444-3575 (Phone)
593 Eddy St, Providence 02903
(401) 444-5120 (Phone), (401) 444-4307 (Fax)
Univ Medicine Gastroenterology
110 Lockwood St SUITE 116, Providence 02903
(401) 444-3575 (Phone)
Certifications:
Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Providence Office
593 Eddy St, Providence 02903
Univ Medicine Gastroenterology
110 Lockwood St SUITE 116, Providence 02903
Rhode Island Hospital
593 Eddy St, Providence 02903
593 Eddy St, Providence 02903
Univ Medicine Gastroenterology
110 Lockwood St SUITE 116, Providence 02903
Rhode Island Hospital
593 Eddy St, Providence 02903
Education:
Medical School
University of Washington
Graduated: 1969
University of Washington
Graduated: 1969
Wnt Proteins And Detection And Treatment Of Cancer
US Patent:
2010020, Aug 12, 2010
Filed:
Feb 5, 2010
Appl. No.:
12/701425
Inventors:
Jack R. Wands - Providence RI, US
Miran Kim - North Providence RI, US
Miran Kim - North Providence RI, US
Assignee:
RHODE ISLAND HOSPITAL, A LIFESPAN-PARTNER - Providence RI
International Classification:
A61K 39/395, A61P 35/00, C12Q 1/02, G01N 33/53, C12Q 1/68
US Classification:
4241381, 435 29, 435 71, 436501, 435 6
Abstract:
The present specification provides, inter alia, methods of using Wnt and FZD proteins and genes, and Wnt- and FZD-specific antibodies and probes in diagnosis and treatment of cancer and for screening test compounds for an ability to treat cancer. Also disclosed are compounds useful for treating cancer such as liver cancer.
Anti-Hydroxylase Antibodies And Uses Thereof
US Patent:
2009001, Jan 8, 2009
Filed:
Mar 25, 2008
Appl. No.:
12/055108
Inventors:
K. Dane Wittrup - Chestnut Hill MA, US
Jack R. Wands - Providence RI, US
Yik Andy Yeung - Cambridge MA, US
Jack R. Wands - Providence RI, US
Yik Andy Yeung - Cambridge MA, US
Assignee:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA
International Classification:
C07K 16/18
US Classification:
5303871
Abstract:
Antibodies, or antigen-binding portions thereof, to aspartyl (asparaginyl) β-hydroxylase are provided. The anti-aspartyl (asparaginyl) β-hydroxylase antibodies, or antigen-binding portions thereof, can modulate activity of aspartyl (asparaginyl) β-hydroxylase.
Anti-Hydroxylase Antibodies And Uses Thereof
US Patent:
7413737, Aug 19, 2008
Filed:
Nov 15, 2004
Appl. No.:
10/989462
Inventors:
K. Dane Wittrup - Chestnut Hill MA, US
Yik Andy Yeung - Cambridge MA, US
Jack R. Wands - Providence RI, US
Yik Andy Yeung - Cambridge MA, US
Jack R. Wands - Providence RI, US
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61K 39/00, A61K 39/395, C12P 21/08, C07K 16/00
US Classification:
4241421, 4241521, 4241551, 5303873, 5303877, 53038815, 5303888
Abstract:
Antibodies, or antigen-binding portions thereof, to aspartyl (asparaginyl) β-hydroxylase are provided. The anti-aspartyl (asparaginyl) β-hydroxylase antibodies, or antigen-binding portions thereof, can modulate activity of aspartyl (asparaginyl) β-hydroxylase.
Thymosin Augmentation Of Genetic Immunization
US Patent:
2005005, Mar 10, 2005
Filed:
Oct 28, 2002
Appl. No.:
10/493411
Inventors:
Jack Wands - Providence RI, US
International Classification:
C07H021/04, A61K039/29
US Classification:
536023720, 424228100
Abstract:
This invention describes the use of thymosin to augment cellular immune responses to hepatitis C virus. Methods for immunizing a subject susceptable to hepatitis C virus infection against such infection, comprising administering to the subject one or more polynucleotides encoding one or more hepatitis C virus peptides, in combination with one or more thymosins, are disclosed. Compositions suitable for immunizing against hepatitis C virus, comprising one or more polynucleotides encoding one or more hepatitis C virus peptides, and one or more thymosins, are also disclosed.
Frizzled Proteins And Detection And Treatment Of Cancer
US Patent:
7867705, Jan 11, 2011
Filed:
Jan 5, 2005
Appl. No.:
11/575627
Inventors:
Jack R. Wands - Providence RI, US
Philippe Merle - Lyons, FR
Suzanne M. De La Monte - East Greenwich RI, US
Philippe Merle - Lyons, FR
Suzanne M. De La Monte - East Greenwich RI, US
Assignee:
Rhode Island Hospital, a Lifespan-Partner - Providence RI
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435 6, 435 723, 436501, 436518
Abstract:
The present specification provides, inter alia, methods of using Wnt and FZD proteins, genes, FZD and Wnt-specific antibodies and probes in diagnosis and treatment of cancer and for screening test compounds for an ability to treat cancer. Also disclosed are compounds useful for treating cancer such as liver cancer.
Wnt Proteins And Detection And Treatment Of Cancer
US Patent:
8158761, Apr 17, 2012
Filed:
Sep 21, 2005
Appl. No.:
11/909308
Inventors:
Jack R. Wands - Providence RI, US
Miran Kim - North Providence RI, US
Miran Kim - North Providence RI, US
Assignee:
Rhode Island Hospital - Providence RI
International Classification:
C07K 16/00
US Classification:
5303881
Abstract:
The present specification provides, inter alia, methods of using Wnt and FZD proteins, genes, FZD and Wnt-specific antibodies and probes in diagnosis and treatment of cancer and for screening test compounds for an ability to treat cancer. Also disclosed are compounds useful for treating cancer such as liver cancer.
Anti-Hydroxylase Antibodies And Uses Thereof
US Patent:
2010001, Jan 14, 2010
Filed:
Sep 3, 2009
Appl. No.:
12/553599
Inventors:
K. Dane Wittrup - Chestnut Hill MA, US
Jack R. Wands - Providence RI, US
Yik Andy Yeung - Pittsburg CA, US
Jack R. Wands - Providence RI, US
Yik Andy Yeung - Pittsburg CA, US
International Classification:
C07K 16/00
US Classification:
5303891
Abstract:
Antibodies, or antigen-binding portions thereof, to aspartyl (asparaginyl) β-hydroxylase are provided. The anti-aspartyl (asparaginyl) β-hydroxylase antibodies, or antigen-binding portions thereof, can modulate activity of aspartyl (asparaginyl) β-hydroxylase.
Treatment Of Glioblastoma With Thymosin-Alpha 1
US Patent:
2006016, Jul 27, 2006
Filed:
Dec 10, 2002
Appl. No.:
10/498050
Inventors:
Jack Wands - Providence RI, US
Suzanne De La Monte - Providence RI, US
Suzanne De La Monte - Providence RI, US
Assignee:
Rhode Island Hospital - Providence RI
International Classification:
A61K 38/17, A61K 31/175
US Classification:
514012000, 514589000
Abstract:
Thymosin-α1 is used as an adjuvant in combination with carmustine (BCNU) as an effective treatment for malignant glioblastoma.